Dublin, July 24, 2020 (GLOBE NEWSWIRE) -- The "Large Volume Wearable Injectors Market (5th Edition), 2020-2030: Focus on Bolus, Basal and Continuous Delivery Devices" report has been added to ResearchAndMarkets.com's offering.

This report features an extensive study of the current market landscape and the likely future evolution of these self-injection devices, over the next ten years. It specifically lays emphasis on the emergence of patient-centric, convenient, cost-effective and user-friendly wearable drug delivery solutions that are capable of administering large volumes of a drug subcutaneously, in the home-care setting.

One of the key objectives of the report was to estimate the existing market size and potential future growth opportunities for large volume wearable injectors. Based on parameters, such as the number of commercialized devices, number of devices under development, price of the device and the annual adoption rate, we have provided an informed estimate on the likely evolution of the market over the period 2020-2030.

The report also features sales forecasts for the overall large volume wearable injectors market with a detailed market segmentation on the:

Chronic diseases, such as diabetes, cardiovascular disorders, neurological disorders, autoimmune disorders and various types of cancer, are known to be the leading causes of death and disability across the world. The clinical conditions associated with these diseases affect patients' overall quality of life. In fact, according to the World Health Organization (WHO), over 50% of the global population is currently estimated to be suffering from at least one chronic disease.

The past few years have witnessed introduction of several innovative pharmaceutical interventions for the treatment of a number of such diseases. However, majority of the available treatment options require parenteral administration of the drug, frequent dosing, and involve repeated hospital visits.

Treatment administration via the parenteral route is also associated with various concerns, such as dosing errors, risk of microbial contamination and needlestick injuries. These are known to be the primary factors affecting medication adherence and, thereby, have a significant impact on therapeutic outcomes. Over the past few years, a number of companies have developed advanced therapeutic delivery solutions (such as autoinjectors, pen injectors, prefilled syringes) to overcome the challenges associated with the administration of both conventional and novel drug/therapy molecules.

In fact, these drug delivery devices can prove to be potential vehicles for drug administration in disease outbreaks/pandemics (such as the one being faced due to the novel corona virus/COVID-19). Amongst modern drug delivery practices, the concept of self-injection has facilitated the administration of medications outside the clinical setting. Such practices also allow reductions in healthcare costs and enable the optimal usage of healthcare resources.

Specifically, large volume wearable injectors used for subcutaneous drug delivery, have become a preferred choice for administration of drugs in the home-care setting. Variants of these wearable devices have been designed to administer highly viscous drugs (such as biologics) in large volumes (more than 1 mL), offering numerous dosing options (basal, bolus or continuous), integrated safety mechanisms, and an almost negligible risk of needlestick injuries. Such devices have captured the interest of several stakeholders in this industry and are being used for the administration of both insulin and non-insulin drugs.

The field is presently witnessing a lot of innovation, such as the development of integrated mobile applications with smart health monitoring, artificial intelligence algorithms and other interesting features (including provisions for reminders, and the ability to connect to web-based portals for sharing medical data with the concerned healthcare providers), visual/audible drug delivery confirmation notifications, automatic drug reconstitution, and error alerts. We believe that such efforts are likely to drive growth in this market over the coming years.

Amongst other elements, the report includes:

In order to account for future uncertainties and to add robustness to our model, we have provided three market forecast scenarios namely the conservative, base and optimistic scenarios, which represent different tracks of the industry's evolution.

The opinions and insights presented in this study were influenced by discussions conducted with several stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals:

Key Questions Answered

Key Topics Covered

1. Preface2. Executive Summary3. Introduction4. Large Volume Wearable Injectors: Current Market Landscape5. Product Competitiveness Analysis6. Large Volume Wearable Injectors: Key Players7. Drug-Device Combinations: Tabulated Profiles8. Partnerships and Collaborations9. Key Acquisition Targets10. Patent Analysis11. Large Volume Wearable Injectors: Likely Drug Candidates12. Emerging Trends on Social Media13. Clinical Trial Analysis14. Case Study: Role of CMOs in Device Development Supply Chain15. Regulatory and Reimbursement Landscape for Medical Devices16. Market Sizing and Opportunity Analysis17. SWOT Analysis18. Executive Insights

Companies Mentioned

For more information about this report visit https://www.researchandmarkets.com/r/p6d8mi

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Go here to read the rest:

Global Large Volume Wearable Injectors Market Outlook to 2030 with Competitive Analysis on 400+ Players - GlobeNewswire